Journal of Hematology & Oncology is the official journal of the Chinese American Hematologist and Oncologist Network.
ABT-199 (venetoclax) and BCL-2 inhibitors in clinical development
With the advent of new agents targeting CD20, Bruton’s tyrosine kinase, and phosphoinositol-3 kinase for chronic lymphoid leukemia (CLL), more treatment options exist than ever before. B-cell lymphoma-2 (BCL-2...